CAS: 71-33-0; 1,3,5-Triazine-2,4(1H,3H)-Dione

上下游产品

CAS号27738-96-1 N-(氯甲酰)异氰酸酯 | CAS号122-51-0 原甲酸三乙酯 | CAS号57-13-6 尿素 | CAS号1898-72-2 2,4-二甲氧基-1,3,5-三嗪 | CAS号27032-78-6 1,3,5-三嗪烷-2,4-二酮 | CAS号2831-66-5 2,4-二氯-1,3,5-三嗪 | CAS号108-19-0 缩二脲 | CAS号61466-03-3 4,4-methine-bis... | CAS号58376-76-4 2,5,2',5'-tetra... | CAS号873-48-3 1-methyl-1,3,5-... | CAS号61851-92-1 6-(4-chlorophen... | CAS号61851-93-2 6-[4-(dimethyla...

📜N-(氯甲酰)异氰酸酯置于三氟乙酸体系中,用 四氢呋喃,二氯甲烷 作为反应溶剂,化学反应生成 5-氮杂尿嘧啶
参考文献:6-Amino-2,4-Dioxo-3,4-Dihydro-1,3,5-Triazine Derivatives And Methods For The Solid Phase Synthesis Thereof
标题:6-Amino-2,4-Dioxo-3,4-Dihydro-1,3,5-Triazine Derivatives And Methods For The Solid Phase Synthesis Thereof
摘要:本发明涉及具有药理活性的取代6-氨基-2,4-二氧-3,4-二氢-1,3,5-三嗪化合物的化学式(I)1,以及用于其制备的固相合成方法,以及其组合库,利用该化合物库进行药物发现,并涉及其药物组合物.

专利信息

专利号:US-2003162992-A1
优先权日:2001-12-14
标 题 :Preparation of intermediates useful in the synthesis of antiviral nucleosides
发明人：WATANABE KYOICHI A; DU JINFA
摘要:The present invention is an efficient process for the manufacture of α-acyloxyacetaldehyde, a key intermediate in the synthesis of 1,3-oxathiolane and 1,3-dioxolane nucleosides.

专利号:US-8492390-B2
优先权日:2002-05-08
标题 :Synthesis of locked nucleic acid derivatives
发明人：DETLEF SORENSEN MADS; WENGEL JESPER; KOCH TROELS; CHRISTENSEN SIGNE M; ROSENBOHM CHRISTOPH; PEDERSEN DANIEL SEJER
权利人:DETLEF SORENSEN MADS; WENGEL JESPER; KOCH TROELS; CHRISTENSEN SIGNE M; ROSENBOHM CHRISTOPH; PEDERSEN DANIEL SEJER; SANTARIS PHARMA AS
摘要:The invention relates to a novel strategy for the synthesis of Locked Nucleic Acid derivatives, such as α- L -oxy-LNA, amino-LNA, α- L -amino-LNA, thio-LNA, α- L -thio-LNA, seleno-LNA and methylene LNA, which provides scalable high yielding reactions utilising intermediates that also can produce other LNA analogues such as oxy-LNA. Also, the compounds of the formula X are important intermediates that may be reacted with varieties of nucleophiles leading to a wide variety of LNA analogues.

专利号:US-4049710-A
优先权日:1976-02-24
标题:Novel carbamimidoyl chlorides and their use in the synthesis of herbicidal triazinediones
发明人：TOCKER STANLEY
权利人:DU PONT
摘要:Carbamimidoyl chlorides of the formula: WHERE R2 is alkyl of 1-4 carbon atoms are useful as intermediates in the synthesis of herbicidal triazinediones of the formula: where R1 is certain organic radicals.

专利号:EP-1501848-B1
优先权日:2002-05-08
标 题 :Synthesis of locked nucleic acid derivatives
发明人：SORENSEN MADS DETLEF; WENGEL JESPER; KOCH TROELS; CHRISTENSEN SIGNE M; ROSENBOHM CHRISTOPH; PEDERSEN DANIEL SEJER
权利人:SANTARIS PHARMA AS
摘要:The invention relates to a novel strategy for the synthesis of Locked Nucleic Acid derivatives, such as alpha-L-oxy-LNA, amino-LNA, alpha-L-amino-LNA, thio-LNA, alpha-L-thio-LNA, seleno-LNA and methylene LNA, which provides scalable high yielding reactions utilising intermediates that also can produce other LNA analogues such as oxy-LNA. Also, the compounds of the formula X are important intermediates that may be reacted with varieties of nucleophiles leading to a wide variety of LNA analogues. (Formula I)

专利号:US-5990341-A
优先权日:1993-11-08
标 题 :Diastereoselective synthesis hydroxyethylene dipeptide isosteres
发明人：LIOTTA DENNIS C; LAGU BHARAT RAMKRISHNA
权利人:UNIV EMORY
摘要:A process for the synthesis of hydroxyethylene dipeptide isosteres from α-N,N-di(protected)amino(alkyl or substituted alkyl) methyl ketones that can be efficiently carried out on an industrial scale. The process proceeds with excellent diastereoselectivity and chemical efficiency, and can be used to prepare a wide variety of hydroxyethylene dipeptide isosteres for a variety of uses, including as HIV-1 protease inhibitors and renin inhibitors.

专利号:WO-2025085030-A1
优先权日:2023-10-18
标 题:Synthesis of semisynthetic penicillin derivatives containing hydrazone-derived thiazolidine and imidazole ring
发明人：SARIPINAR EMIN; BURAN SUMEYYE
权利人:ERCIYES UNIV
摘要:The present invention relates to the novel semi-synthetic thiazolidine and imidazole penicillin, pharmaceutically acceptable derivatives thereof and their synthesis method that may cause biologically significant changes by the N-acylation reaction of 6-aminopenicillanic (6-APA) using new trisubstituted thiazolidine and imidazole acetyl chloride derivatives. The invention also relates to pharmaceutical compositions comprising these compounds and their use for therapeutic treatment in the human or animal body.